Mold Illness & CIRS: Root Causes, Symptoms & Integrative Recovery

What Is Mold Illness?

Mold illness — formally known as Chronic Inflammatory Response Syndrome (CIRS) — is a complex, multi-system condition triggered by exposure to water-damaged buildings (WDB) and the biotoxins they produce. Unlike a simple allergic reaction, CIRS involves a dysregulated innate immune response that fails to clear biotoxins from the body, leading to widespread, chronic inflammation.

Coined and extensively researched by Dr. Ritchie Shoemaker, CIRS affects an estimated 25% of the population who carry specific HLA-DR gene variants that impair biotoxin clearance. For these individuals, even brief or low-level mold exposure can trigger a cascade of debilitating symptoms that persist long after the exposure ends.

What Causes CIRS?

CIRS is not caused by mold alone. It results from exposure to a complex mixture of biotoxins found in water-damaged environments, including:

Mycotoxins — toxic secondary metabolites produced by mold species such as Stachybotrys, Aspergillus, and Penicillium
Bacterial endotoxins — from gram-negative bacteria thriving in damp environments
Beta-glucans — inflammatory cell wall components of fungi
Actinomycetes — thermophilic bacteria found in HVAC systems and wet insulation
Volatile organic compounds (VOCs) — off-gassed by mold colonies and building materials

The key driver of CIRS is not the toxin itself but the body's inability to mount an effective immune response to clear it. In genetically susceptible individuals, biotoxins bind to receptors and trigger a self-perpetuating inflammatory loop that affects virtually every organ system.

The HLA-DR Gene Connection

Approximately 24–25% of people carry HLA-DR immune response gene variants that prevent their antigen-presenting cells from recognizing and tagging biotoxins for elimination. Without this recognition, the immune system cannot produce the antibodies needed to clear the toxins, which then recirculate and continue to drive inflammation indefinitely.

This genetic susceptibility explains why some people become severely ill in a moldy building while others in the same environment remain unaffected. It also explains why CIRS patients do not recover simply by leaving the exposure — the inflammatory cascade continues without targeted intervention.

How CIRS Affects the Body

CIRS is a systemic illness. Biotoxins and the inflammatory mediators they trigger affect multiple physiological pathways simultaneously:

Cytokine dysregulation — elevated TGF-β1, MMP-9, and C4a drive systemic inflammation
Hypothalamic-pituitary disruption — impaired MSH (melanocyte-stimulating hormone) production affects sleep, pain regulation, and immune balance
Leptin resistance — elevated leptin with MSH deficiency creates a vicious cycle of fatigue and weight dysregulation
VEGF suppression — reduced vascular endothelial growth factor impairs oxygen delivery to tissues
ADH/osmolality dysregulation — leads to excessive thirst, frequent urination, and electrolyte imbalances
Coagulation abnormalities — elevated PAI-1 increases clotting risk and impairs circulation
Neurological impact — biotoxins cross the blood-brain barrier, causing cognitive dysfunction, anxiety, and neuroinflammation

Symptoms of Mold Illness & CIRS

CIRS presents with a wide and seemingly unrelated constellation of symptoms, which is why it is frequently misdiagnosed as fibromyalgia, chronic fatigue syndrome, depression, or anxiety. Common symptoms include:

Profound fatigue and post-exertional malaise
Cognitive impairment — brain fog, memory loss, difficulty concentrating
Headaches, often severe or migratory
Muscle aches, joint pain, and morning stiffness
Shortness of breath, air hunger, and chest tightness
Sinus congestion, chronic cough, and unusual sensitivity to light
Numbness, tingling, and static-like sensations
Mood disturbances — anxiety, depression, irritability
Sleep disruption and non-restorative sleep
Excessive thirst and frequent urination
Abdominal pain, bloating, and diarrhea
Temperature dysregulation and night sweats

The Shoemaker protocol uses a cluster of 37 symptoms across 13 symptom clusters to identify CIRS. The presence of 8 or more clusters is considered highly suggestive of biotoxin illness.

Diagnosing CIRS

Diagnosis requires a combination of clinical history, symptom cluster analysis, genetic testing, and laboratory biomarkers. Key diagnostic tools include:

Visual Contrast Sensitivity (VCS) test — a validated screening tool that detects neurological impairment caused by biotoxins; available online at survivingmold.com
HLA-DR genotyping — identifies genetic susceptibility to biotoxin illness
Inflammatory biomarkers — TGF-β1, C4a, MMP-9, MSH, VEGF, ADH/osmolality, leptin, and cortisol
ERMI testing — Environmental Relative Moldiness Index; a DNA-based dust test that quantifies mold species in the home or workplace
HERTSMI-2 score — a subset of ERMI focused on the 5 most pathogenic mold species relevant to CIRS

A certified CIRS practitioner (trained in the Shoemaker protocol) is essential for accurate diagnosis and treatment sequencing.

The Shoemaker Protocol: A Step-by-Step Approach

The Shoemaker protocol is a sequential, evidence-based treatment framework. Each step must be completed in order, as skipping steps reduces efficacy and can worsen outcomes.

Step 1: Remove from Exposure

The first and most critical step is identifying and eliminating the source of biotoxin exposure. This means leaving the water-damaged building — whether home, workplace, or school — and ensuring that personal belongings (clothing, furniture, books) are not cross-contaminating the new environment. ERMI/HERTSMI-2 testing of the new environment is strongly recommended before moving in.

Step 2: Bind Biotoxins with Cholestyramine or Welchol

Prescription bile acid sequestrants — cholestyramine (CSM) or colesevelam (Welchol) — bind biotoxins in the gut and prevent their reabsorption via enterohepatic recirculation. This is the primary mechanism for reducing the total biotoxin burden. Treatment typically lasts 30 days, with VCS testing used to confirm response.

Step 3: Eradicate MARCoNS

MARCoNS (Multiple Antibiotic Resistant Coagulase Negative Staphylococci) is a deep nasal biofilm infection found in approximately 80% of CIRS patients. It perpetuates MSH suppression and must be eradicated using BEG nasal spray (Bactroban/EDTA/Gentamicin) or similar compounded formulas before MSH can recover.

Step 4: Correct Antigenic Proteins (MMP-9, TGF-β1)

Elevated MMP-9 is addressed with fish oil and high-amylose resistant starch. Elevated TGF-β1 may require losartan (an angiotensin receptor blocker used off-label) to reduce fibrotic signaling and restore immune balance.

Step 5: Correct ADH/Osmolality

ADH dysregulation is addressed with DDAVP (desmopressin) under physician supervision, along with electrolyte support and hydration strategies.

Step 6: Correct Low MSH

MSH is the master regulatory hormone in CIRS. Low MSH drives pain, sleep disruption, immune dysregulation, and leaky gut. VIP (vasoactive intestinal peptide) nasal spray — the final step in the protocol — helps restore MSH and is only used after all prior steps are complete and the patient is confirmed to be in a clean environment.

Step 7: Correct VEGF and Correct Prothrombotic States

Low VEGF is addressed with exercise and specific nutritional support. Elevated PAI-1 may require nattokinase or lumbrokinase under practitioner guidance to reduce clotting risk.

Step 8: VIP Nasal Spray

Vasoactive intestinal peptide (VIP) is a neuropeptide that regulates inflammation, restores MSH, improves VEGF, and supports pulmonary function. It is the most powerful tool in the Shoemaker protocol and is reserved for patients who have completed all prior steps and are confirmed to be in a mold-free environment.

Integrative & Supportive Strategies

Alongside the Shoemaker protocol, integrative approaches can support recovery and reduce the overall inflammatory burden:

Binders beyond CSM — activated charcoal, zeolite, bentonite clay, and modified citrus pectin can provide additional biotoxin binding support, particularly for those who cannot tolerate prescription binders
Glutathione — supports phase II liver detoxification and reduces oxidative stress from mycotoxin exposure; liposomal or nebulized forms are preferred
Sauna therapy — far-infrared sauna promotes mycotoxin excretion through sweat; start low and slow to avoid Herxheimer reactions
Gut repair — mold illness frequently damages the intestinal lining; L-glutamine, colostrum, zinc carnosine, and a low-amylose diet support gut healing
Nervous system support — vagus nerve stimulation, breathwork, and trauma-informed somatic therapies address the neurological and autonomic dysregulation common in CIRS
Mold-free diet — a low-amylose, low-mycotoxin diet (avoiding corn, peanuts, dried fruits, alcohol, and high-sugar foods) reduces the dietary mycotoxin load and supports binder efficacy
Air filtration — HEPA and activated carbon air purifiers in the living environment reduce ongoing airborne exposure during recovery

The Role of Mold in Broader Chronic Illness

CIRS does not exist in isolation. Mold illness frequently co-occurs with and exacerbates other chronic conditions, including:

Lyme disease and co-infections — biotoxin illness and tick-borne illness share overlapping immune pathways and often require concurrent treatment
MCAS (Mast Cell Activation Syndrome) — mycotoxins are potent mast cell triggers; CIRS patients frequently develop MCAS as a secondary condition
POTS and dysautonomia — autonomic nervous system dysregulation is common in CIRS and may persist even after biotoxin clearance
Autoimmune conditions — chronic biotoxin-driven inflammation can trigger or worsen autoimmune disease in susceptible individuals

Addressing mold illness is often a prerequisite for meaningful recovery from these overlapping conditions.

Finding a CIRS-Literate Practitioner

CIRS remains poorly understood in conventional medicine. Finding a practitioner trained in the Shoemaker protocol is essential. Resources include:

survivingmold.com — Dr. Shoemaker's official resource; includes a practitioner directory, VCS testing, and protocol documentation
ISEAI (International Society for Environmentally Acquired Illness) — a professional organization for practitioners specializing in environmentally acquired illness
Functional and integrative medicine practitioners — many are familiar with CIRS and can order the necessary biomarker panels

Key Takeaways

CIRS is a genetically mediated, multi-system inflammatory illness triggered by biotoxin exposure in water-damaged buildings
Approximately 25% of the population is genetically susceptible and cannot clear biotoxins without targeted intervention
Diagnosis requires clinical history, VCS testing, HLA-DR genotyping, and a panel of inflammatory biomarkers
The Shoemaker protocol provides a sequential, evidence-based treatment framework that must be followed in order
Integrative strategies — binders, glutathione, sauna, gut repair, and nervous system support — complement the protocol and support whole-body recovery
Mold illness frequently co-occurs with Lyme, MCAS, POTS, and autoimmune conditions; addressing CIRS is often foundational to broader recovery